The COVID-19 outbreak is an unprecedented event in terms of its impact on public health and the global economy. While we may see the development of an immunization strategy as the ultimate solution, sequencing the virus with Next-Generation Sequencing (NGS) provides useful diagnostic and research findings to impact the course of this pandemic. As a provider of NGS analysis solutions spanning clinical and research capabilities, Golden Helix has a number of analytical solutions relevant to these different use cases for the analysis of the SARS-CoV-2 virus. This webcast discusses the following subjects: -Diagnosis and viral identification: Secondary solutions to diagnose COVID-19 and identify which virus genomes are present in total RNA samples -Sample cluster: Cohort analysis in SVS to use unsupervised learning PCA to find similarly typed strains based on public sequence data -Clinical analysis: High throughput per sample analysis including variant analysis and clinical reporting Golden Helix prides itself on our ability to capture and utilize the most up-to-date data to streamline your analysis. We hope you enjoy this live look at how Golden Helix's bioinformatics software can be used to explore the sample grouping and genetic composition of the SARS-CoV-2 virus.

1. FAS Manager – Darby Kammeraad

4. FAS Manager – Darby Kammeraad

5. NIH Grant Funding Acknowledgments
•
•
•
•
•
•
•
•

9. o
o
o
o
o
o
o

12. •
•
•
•
•
•

13. •
➢
➢
•
•
•

14. •
•
•
•
•
•
•

19. •
•
•
•
•

24. NIH Grant Funding Acknowledgments
•
•
•
•
•
•
•
•